Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • CLFougner
    Junior Member
    • Mar 2016
    • 2

    #1

    Compare mouse cancer sequence data with COSMIC database

    I'm working with whole exome sequence data from a mouse breast cancer model. I've done mutation calling using the GATK best practices workflow (BWA mem (mm10) -> Picard deduplicate -> base quality score recalibration -> Mutect2. Annotated .vcfs with SnpEff). I now wanted to compare my variants to the COSMIC data base to see if the orthologous variants have been found in human, and am having trouble figuring out the most appropriate way to do this.

    My first thought was to convert my VCF files to .bed files and use the UCSC liftover tool to convert the files from m10 to hg19. I've however also found a publication in which they perform what I'm looking to do, and in their methods they write:

    Variants were compared to known human somatic mutations as available via the COSMIC database38. Briefly, the mouse and human sequences for homologous proteins were pairwise aligned using Clustal Omega39 and the human protein position homolo- gous to the mouse mutation was used to query COSMIC for known missense and nonsense mutations at or surrounding this peptide position. Local conservation was determined after sequence alignment using a 6 10 amino acid residue window surrounding the substituted amino acid.
    I've looked into Clustal Omega, but I'm having trouble understanding how to implement it into this sort of workflow.

    I'm wondering if anyone has done this sort of analysis, and what workflow you've had the most success with?

    Thanks!
  • tristan dubos
    Member
    • Dec 2015
    • 39

    #2
    Hi ,
    I looked the Clustal Omega and you can only compared homologous by pair ? and the think is how to automatize it ?

    Trist

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...